Literature DB >> 22802230

Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.

E Mawhinney1, O M Gray, F McVerry, G V McDonnell.   

Abstract

An elderly female smoker presented with nausea and anorexia. Imaging and histopathology were consistent with a diagnosis of small cell lung cancer (SCLC). She subsequently developed a progressive sensorimotor neuropathy with high titres of anti-Hu antibodies. Development of the neuropathy was associated with marked regression in the lung neoplasm. Repeat investigation with radioimaging and bronchoscopy showed no evidence of neoplasia. Paraneoplastic sensorimotor neuropathies are commonly associated with SCLC particularly in the presence of anti-Hu antibodies. Regression of SCLC with anti-Hu antibodies has only been reported twice previously. The authors believe this case supports the theory that anti-Hu antibodies confer anti-tumour activity causing tumour regression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22802230      PMCID: PMC3038026          DOI: 10.1136/bcr.01.2009.1486

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors.

Authors:  Patricia Tai; Jon Tonita; Edward Yu; David Skarsgard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

3.  Spontaneous complete remission of a non-small cell lung cancer associated with anti-Hu antibody syndrome.

Authors:  Jean-Louis Pujol; Anne-Laure Godard; William Jacot; Pierre Labauge
Journal:  J Thorac Oncol       Date:  2007-02       Impact factor: 15.609

4.  Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Authors:  F Graus; J Dalmou; R Reñé; M Tora; N Malats; J J Verschuuren; F Cardenal; N Viñolas; J Garcia del Muro; C Vadell; W P Mason; R Rosell; J B Posner; F X Real
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

Review 5.  Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour.

Authors:  R D Voltz; J B Posner; J Dalmau; F Graus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

6.  Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.

Authors:  Jean-Philippe Camdessanché; Jean-Christophe Antoine; Jérôme Honnorat; Christophe Vial; Philippe Petiot; Philippe Convers; Daniel Michel
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

7.  Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.

Authors:  C F Lucchinetti; D W Kimmel; V A Lennon
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

8.  Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies.

Authors:  R B Darnell; L M DeAngelis
Journal:  Lancet       Date:  1993-01-02       Impact factor: 79.321

9.  Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer.

Authors:  Sharlene Gill; Nevin Murray; Josep Dalmau; Brian Thiessen
Journal:  Can J Neurol Sci       Date:  2003-08       Impact factor: 2.104

  9 in total
  8 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report.

Authors:  Katherina Bernadette Sreter; Blazenka Barisic; Marija Barisic Kutija; Suzana Kukulj; Miroslav Samarzija
Journal:  Mol Clin Oncol       Date:  2017-05-08

3.  The great masquerader of malignancy: chronic intestinal pseudo-obstruction.

Authors:  Josephine A Taverna; Hani M Babiker; Seongseok Yun; Maria C Bishop; Sarah Lau-Braunhut; Paul N Meyer; Thomas Enzler
Journal:  Biomark Res       Date:  2014-12-05

4.  Spontaneous regression of a pulmonary adenocarcinoma after core needle biopsy.

Authors:  Cristiana Marques; Henrique Queiroga; Margarida Marques; Conceição Moura
Journal:  Autops Case Rep       Date:  2017-09-30

5.  Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort.

Authors:  Paul Maddison; Alexander F Lipka; Paul Gozzard; Girija Sadalage; Philip A Ambrose; Bethan Lang; Jan J Verschuuren
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

6.  Complete spontaneous remission of small cell lung cancer in the absence of specific treatment: A case report.

Authors:  Sung Heon Song; Chang Won Ha; Changhwan Kim; Gil Myeong Seong
Journal:  Thorac Cancer       Date:  2021-08-20       Impact factor: 3.500

7.  Bilateral Vocal Cord Paralysis and Cervicolumbar Radiculopathy as the Presenting Paraneoplastic Manifestations of Small Cell Lung Cancer: A Case Report and Literature Review.

Authors:  Jeffrey C Yeung; C Elizabeth Pringle; Harmanjatinder S Sekhon; Shaun J Kilty; Kristian Macdonald
Journal:  Case Rep Otolaryngol       Date:  2016-09-07

8.  Spontaneous Regression of Small Cell Lung Carcinoma and Associated Hemichorea.

Authors:  Koichi Shibata; Yoshiko Nishimura; Hiroshi Sakura
Journal:  Intern Med       Date:  2021-06-19       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.